CCP
SNY icon

Clough Capital Partners’s Sanofi SNY Stock Holding History

Clough Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-322,000
Closed -$16M – 179
2023
Q4 		$16M Buy
322,000
+47,600
+17% +$2.33M 1.77% 15
2023
Q3 		$14.7M Buy
+274,400
New +$14.6M 1.58% 16
2015
Q2 		– Sell
-372,203
Closed -$18.4M – 236
2015
Q1 		$18.4M Sell
372,203
-143,000
-28% -$6.84M 0.61% 71
2014
Q4 		$23.5M Buy
515,203
+306,703
+147% +$14.9M 0.84% 41
2014
Q3 		$11.8M Sell
208,500
-3,300
-2% -$177K 0.44% 80
2014
Q2 		$11.3M Sell
211,800
-2,500
-1% -$133K 0.36% 98
2014
Q1 		$11.2M Buy
214,300
+900
+0.4% +$45.6K 0.35% 95
2013
Q4 		$11.4M Buy
213,400
+53,700
+34% +$2.77M 0.38% 88
2013
Q3 		$8.09M Buy
+159,700
New +$8.13M 0.25% 128

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Clough Capital Partners's SNY Position: Q1 2024 in Review

Clough Capital Partners sold out of Sanofi (SNY) in Q1 2024, closing a stake of 322,000 shares — an estimated $16M sold.

Clough Capital Partners first reported a position in SNY in Q3 2013 and held it in 9 quarters. The position peaked at $23.5M in Q4 2014. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • Clough Capital Partners reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
  • Clough Capital Partners sold 322,000 Sanofi shares in Q1 2024, an estimated $16M.
  • Clough Capital Partners first reported a position in Sanofi in Q3 2013 and held it in 9 quarters.
  • Clough Capital Partners's Sanofi position peaked at $23.5M in Q4 2014.
  • 713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Clough Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.